Silei Sui

730 total citations
13 papers, 474 citations indexed

About

Silei Sui is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Silei Sui has authored 13 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Silei Sui's work include RNA modifications and cancer (3 papers), Ferroptosis and cancer prognosis (3 papers) and RNA Research and Splicing (3 papers). Silei Sui is often cited by papers focused on RNA modifications and cancer (3 papers), Ferroptosis and cancer prognosis (3 papers) and RNA Research and Splicing (3 papers). Silei Sui collaborates with scholars based in China and United States. Silei Sui's co-authors include Wuguo Deng, Wei Guo, Yi‐Jun Hua, Zongjuan Li, Yuqing Xiong, Wendan Yu, Michael Ntim, Caiming Xu, Sheng Hu and Guangyu Luo and has published in prestigious journals such as Carcinogenesis, Seminars in Cancer Biology and Cell Death and Disease.

In The Last Decade

Silei Sui

12 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silei Sui China 11 248 192 134 131 110 13 474
Miaolin Zhu China 12 234 0.9× 288 1.5× 131 1.0× 119 0.9× 113 1.0× 25 543
Susan Morand United States 7 211 0.9× 239 1.2× 118 0.9× 154 1.2× 131 1.2× 13 506
Shunli Peng China 9 234 0.9× 194 1.0× 139 1.0× 168 1.3× 76 0.7× 14 451
Elena Vagia United States 9 226 0.9× 256 1.3× 125 0.9× 153 1.2× 82 0.7× 25 493
Katsuharu Saito Japan 13 256 1.0× 208 1.1× 83 0.6× 112 0.9× 159 1.4× 26 476
Marco Zanotto Italy 9 221 0.9× 254 1.3× 85 0.6× 118 0.9× 134 1.2× 13 489
Gabriela Raso United States 5 215 0.9× 243 1.3× 186 1.4× 104 0.8× 161 1.5× 6 532
Tomás G. Lyons United States 10 219 0.9× 219 1.1× 106 0.8× 96 0.7× 60 0.5× 18 442
Qiaoliang Zhu China 11 382 1.5× 127 0.7× 147 1.1× 201 1.5× 106 1.0× 21 585

Countries citing papers authored by Silei Sui

Since Specialization
Citations

This map shows the geographic impact of Silei Sui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silei Sui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silei Sui more than expected).

Fields of papers citing papers by Silei Sui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silei Sui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silei Sui. The network helps show where Silei Sui may publish in the future.

Co-authorship network of co-authors of Silei Sui

This figure shows the co-authorship network connecting the top 25 collaborators of Silei Sui. A scholar is included among the top collaborators of Silei Sui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silei Sui. Silei Sui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Sui, Silei, et al.. (2025). circ-EGFR is a predictor of response to Cetuximab and a potential target in colorectal cancer. EMBO Molecular Medicine. 17(12). 3525–3554.
2.
Li, Yuan, Silei Sui, & Ajay Goel. (2024). Extracellular vesicles associated microRNAs: Their biology and clinical significance as biomarkers in gastrointestinal cancers. Seminars in Cancer Biology. 99. 5–23. 21 indexed citations
3.
Li, Jinyu, Caixia Ren, Ning Wang, et al.. (2021). Identification of differentially expressed genes-related prognostic risk model for survival prediction in breast carcinoma patients. Aging. 13(12). 16577–16599. 6 indexed citations
4.
Xu, Caiming, Silei Sui, Yuru Shang, et al.. (2020). The landscape of immune cell infiltration and its clinical implications of pancreatic ductal adenocarcinoma. Journal of Advanced Research. 24. 139–148. 54 indexed citations
5.
Qian, Long, Xin An, Miao Chen, et al.. (2020). PUF60/AURKA Axis Contributes to Tumor Progression and Malignant Phenotypes in Bladder Cancer. Frontiers in Oncology. 10. 568015–568015. 20 indexed citations
6.
Li, Zongjuan, Yang Zhang, Silei Sui, et al.. (2020). Targeting HMGB3/hTERT axis for radioresistance in cervical cancer. Journal of Experimental & Clinical Cancer Research. 39(1). 243–243. 34 indexed citations
7.
Li, Wenbin, Yue Yan, Zongheng Zheng, et al.. (2020). Targeting the NCOA3-SP1-TERT axis for tumor growth in hepatocellular carcinoma. Cell Death and Disease. 11(11). 1011–1011. 16 indexed citations
8.
Yu, Wendan, Yi‐Jun Hua, Huijuan Qiu, et al.. (2020). PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer. Cell Death and Disease. 11(7). 506–506. 120 indexed citations
9.
Sui, Silei, Xin An, Caiming Xu, et al.. (2020). An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer. Theranostics. 10(26). 11938–11949. 105 indexed citations
10.
Qian, Long, Yi‐Jun Hua, Liru He, et al.. (2020). Poly(U) binding splicing factor 60 promotes renal cell carcinoma growth by transcriptionally upregulating telomerase reverse transcriptase. International Journal of Biological Sciences. 16(15). 3002–3017. 10 indexed citations
11.
Jiang, Wei, Yue Yan, Manyu Chen, et al.. (2020). Aspirin enhances the sensitivity of colon cancer cells to cisplatin by abrogating the binding of NF-κB to the COX-2 promoter. Aging. 12(1). 611–627. 43 indexed citations
12.
Song, Chen, Ning Wang, Tao Qin, et al.. (2019). RNA-binding protein CUGBP1 controls the differential INSR splicing in molecular subtypes of breast cancer cells and affects cell aggressiveness. Carcinogenesis. 41(9). 1294–1305. 13 indexed citations
13.
Qin, Tao, Silei Sui, Chen Song, et al.. (2017). Exceptionally high UBE2C expression is a unique phenomenon in basal-like type breast cancer and is regulated by BRCA1. Biomedicine & Pharmacotherapy. 95. 649–655. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026